Detection of EBV and CMV coinfection among patients under hemodialysis
Keywords:
EBV, CMV, coinfection, hemodialysisAbstract
Background: CMV and EBV infections are a common cause of complications in patients with a variety of chronic diseases, and they are one of the most significant factors preventing patients from completing their treatment successfully. Aim of the study: The study's goal was to determine the frequency of EBV and CMV infections in patients receiving hemodialysis and how that frequency correlated with serum IL-6 levels. Patients and Methods: A cross sectional study was carried out in Kirkuk city from 15th of January 2021 to 15th of November 2021. A total of 87 hemodialysis patients and 33 healthy control group whose ages were between 30-75 years old. These patients admitted to Kirkuk General Hospital. An interview was carried out with these patients using questionnaire form designed by the investigator. Four ml of blood was collected from each person enrolled in this study for detection of specific EBV, and CMV IgM antibodies and Interleukin-6 by using ELISA technique.Results: The study showed that the highest rate of EBV-IgM Abs was occurred in hemodialysis patients (43.68%) comparing with the control group(9.09%), P<0.01. CMV –IgM was found 47.13% of HD patients and 21.21% of the control group, P<0.01.
Downloads
References
de Melo Silva J, Pinheiro-Silva R, Dhyani A, Pontes GS. Cytomegalovirus and Epstein-Barr infections: Prevalence and impact on patients with hematological diseases. BioMed Research International. 2020 Oct 26;2020. DOI: https://doi.org/10.1155/2020/1627824
Vanichanan J, Udomkarnjananun S, Avihingsanon Y, Jutivorakool K. Common viral infections in kidney transplant recipients. Kidney Research and Clinical Practice. 2018 Dec;37(4):323. DOI: https://doi.org/10.23876/j.krcp.18.0063
Chabay P, Preciado MV. Epidemiology of Epstein-Barr virus-associated pediatric lymphomas from Argentina. Bol Med Hosp Infant Mex 2016;73:47–54. [PubMed] [Google Scholar] DOI: https://doi.org/10.1016/j.bmhimx.2015.12.002
Maeda E, Akahane M, Kiryu S, Kato N, Yoshikawa T, Hayashi N, et al. Spectrum of Epstein-Barr virus-related diseases: a pictorial review. Jpn J Radiol 2009;27:4–19. [PubMed] [Google Scholar] DOI: https://doi.org/10.1007/s11604-008-0291-2
Pagano JS. Is Epstein-Barr virus transmitted sexually? JID 2007;195:469–470. [PubMed] [Google Scholar] DOI: https://doi.org/10.1086/510861
Sitki-Green D, Covington M, Raab-Traub N. Compartmentalization and transmission of multiple epstein-barr virus strains in asymptomatic carriers. J Virol 2003;77:1840–1847. [PMC free article] [PubMed] [Google Scholar] DOI: https://doi.org/10.1128/JVI.77.3.1840-1847.2003
Abecassis M, Bartlett ST, Collins AJ, Davis CL, Delmonico FL, Friedewald JJ, et al. Kidney transplantation as primary therapy for end-stage renal disease: a national kidney foundation/kidney disease outcomes quality initiative (NKF/KDOQI™) conference. Clin J Am Soc Nephrol 2008;3:471–480. [PMC free article] [PubMed] [Google Scholar] DOI: https://doi.org/10.2215/CJN.05021107
Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 2008;3:1526–1533. DOI: https://doi.org/10.2215/CJN.00950208
Hodinka RL. Human cytomegalovirus. In: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnick DW, editors. Manual of Clinical Microbiology. 10th ed. Washington, DC: ASM Press; 2011. pp. 1558–74. [Google Scholar]
Kamar N, Mengelle C, Esposito L, Guitard J, Mehrenberger M, Lavayssière L, et al. Predictive factors for cytomegalovirus reactivation in cytomegalovirus-seropositive kidney-transplant patients. J Med Virol. 2008;80:1012–7. [PubMed] [Google Scholar] DOI: https://doi.org/10.1002/jmv.21176
Cheng JW, Chen YC, Tian YC, Fang JT, Yang CW. Coinfection of cytomegalovirus and miliary tuberculosis in a post-renal transplant recipient. J Nephrol. 2007;20:114–8. [PubMed] [Google Scholar]
Jain M, Duggal S, Chugh TD. Cytomegalovirus infection in non-immunosuppressed critically ill patients. J Infect Dev Ctries. 2011;5:571–9. [PubMed] [Google Scholar] DOI: https://doi.org/10.3855/jidc.1487
Orasch C, Conen A. Severe primary cytomegalovirus infection in the immunocompetent adult patient: A case series. Scand J Infect Dis. 2012;44:987–91. [PubMed] [Google Scholar] DOI: https://doi.org/10.3109/00365548.2012.697637
Merlo A, Turrini R, Dolcetti R, Martorelli D, Muraro E, Comoli P, et al. The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders. Haemato. 2010; 95: 1769–1777. DOI: https://doi.org/10.3324/haematol.2010.023689
Ascherio A., Munger K.L., “Epstein-Barr virus infection and multiple sclerosis: a review”. Journal of Neuroimmune Pharmacology 2010; 5 (3): 271–7 DOI: https://doi.org/10.1007/s11481-010-9201-3
11.Rahil Nahid Samiei, Shahab Mahmoudvand, Somayeh Shokri, Manoochehr Makvandi, Heshmatollah Shahbazian, Roya Pirmoradi, Shokouh Shayanpur, Kimia Makvandi., The incidence of hemodialysis patients with Epstein-Barr virus,) Ahvaz, Iran. J Microbiol, Iran. 2019; 11(1): 75–79.
Ternák G, Szúcs G, Uj M. The serological signs of the Epstein-Barr virus (EBV) activity in the elderly. Acta Microbiologica et Immunologica Hungarica. 1997; 44(2):133–140.
Vedat Schwenger, Christian Morath, Alex Hofmann, Oskar Hoffmann, Martin Zeier, Eberhard Ritz. Late referral - a major cause of poor outcome in the very elderly dialysis patient. Neph. Dialy. Transpl.; 2006;21(4):962–967. DOI: https://doi.org/10.1093/ndt/gfk030
Yamamoto T., Nakajima Y., Yamamoto M., Hironaka T., Hirai K., Nakamura Y. Epstein-Barr virus infection of renal proximal tubule cells: possible role in chronic interstitial nephritis. J Clin Invest. 1999; 104 (12): 1673–1681. DOI: https://doi.org/10.1172/JCI7286
Banas, B.; Böger, C.; Lückhoff, G.; Krüger, B.; Batzilla, J.; Schemmerer, M.; Köstler, J.; Deml, L.; Leicht, J.; Krämer, B. K. Validation of the Suitability of Lophius Kits T-Track® CMV and T-Track® EBV to Assess the Functionality of Cell-Mediated Immunity (CMI) in Hemodialysis Patients Transplantation: 2012; 94 - Issue 10S - p 1175 DOI: https://doi.org/10.1097/00007890-201211271-02334
R. J. Hoagland, “The clinical manifestations of infectious mononucleosis: a report of two hundred cases,” AJMS. 1960; 240 (7): 55–63,. Google Scholar DOI: https://doi.org/10.1097/00000441-196007000-00003
18.E. Stevens, “Infectious mononucleosis: a clinical analysis of 210 sporadic cases,” Virginia Medical Monthly, 1952; 79 (2) :74–80. Google Scholar
Toussirot E., Roudier J. “Epstein-Barr virus in autoimmune diseases”. Best Pract. Res.: Clin. Rheumatol. 2008; 22 (5): 883–96. https://doi.org/10.1016/j.berh.2008.09.007, DOI: https://doi.org/10.1016/j.berh.2008.09.007
Taraz M, Khatami MR, Dashti-Khavidaki S, Akhonzadeh S, Noorbala AA, Ghaeli P, Taraz S. Sertraline decreases serum level of interleukin-6 (IL-6) in hemodialysis patients with depression: results of a randomized double-blind, placebo-controlled clinical trial. International immunopharmacology. 2013 Nov 1;17(3):917-23. DOI: https://doi.org/10.1016/j.intimp.2013.09.020
Odumade, O. A.; Hogquist, Balfour. “Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections”. ASM. 2011; 24 (1): 193–209. DOI: https://doi.org/10.1128/CMR.00044-10
Ridker PM, Devalaraja M, Baeres FM, Engelmann MD, Hovingh GK, Ivkovic M, Lo L, Kling D, Pergola P, Raj D, Libby P. IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial. The Lancet. 2021 May 29;397(10289):2060-9. DOI: https://doi.org/10.1016/S0140-6736(21)00520-1
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
